Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery

Sanofi

Status and phase: Completed; Phase 3

Conditions: Hip Fractures

Treatments: Drug: enoxaparin (XRP4563)

Study type: Interventional

Funder types: Industry

Identifiers

NCT00685958

SFY6771

Details and patient eligibility

About

The purpose of this study is to evaluate the effects of enoxaparin on bleeding and venous blood clots in patients with hip fracture surgery.

Enrollment: 54 patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• femoral neck inside or outside fracture

Exclusion criteria

• any major surgery on lower limbs within 3 months
• clinical signs of deep vein thrombosis
• use of non-steroidal anti-inflammatory drugs
• severe hepatic disease or renal insufficiency

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)